These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
157 related articles for article (PubMed ID: 8032587)
1. Reduced endothelium-dependent relaxation at enhanced NO release in hearts of hypercholesterolaemic rabbits. Woditsch I; Schrör K Br J Pharmacol; 1994 Apr; 111(4):1035-40. PubMed ID: 8032587 [TBL] [Abstract][Full Text] [Related]
2. Vasorelaxant and antiaggregatory properties of the endothelium: a comparative study in normocholesterolaemic and hereditary and dietary hypercholesterolaemic rabbits. Greenlees C; Wainwright CL; Wadsworth RM Br J Pharmacol; 1996 Dec; 119(7):1470-6. PubMed ID: 8968557 [TBL] [Abstract][Full Text] [Related]
3. Altered coronary dilation in deoxycorticosterone acetate-salt hypertension. Millette E; de Champlain J; Lamontagne D J Hypertens; 2000 Dec; 18(12):1783-93. PubMed ID: 11132602 [TBL] [Abstract][Full Text] [Related]
4. Effects of bradykinin in the rat isolated perfused heart: role of kinin receptors and endothelium-derived relaxing factor. Baydoun AR; Woodward B Br J Pharmacol; 1991 Jul; 103(3):1829-33. PubMed ID: 1657268 [TBL] [Abstract][Full Text] [Related]
5. The role of myoendothelial cell contact in non-nitric oxide-, non-prostanoid-mediated endothelium-dependent relaxation of porcine coronary artery. Kühberger E; Groschner K; Kukovetz WR; Brunner F Br J Pharmacol; 1994 Dec; 113(4):1289-94. PubMed ID: 7889285 [TBL] [Abstract][Full Text] [Related]
6. Oral cicaprost protects from hypercholesterolaemia-induced impairment of coronary vasodilation. Woditsch I; Hohlfeld T; Strobach H; Schrör K Agents Actions Suppl; 1992; 37():297-304. PubMed ID: 1632304 [TBL] [Abstract][Full Text] [Related]
7. Endothelial dysfunction of coronary resistance vessels in apoE-/- mice involves NO but not prostacyclin-dependent mechanisms. Gödecke A; Ziegler M; Ding Z; Schrader J Cardiovasc Res; 2002 Jan; 53(1):253-62. PubMed ID: 11744035 [TBL] [Abstract][Full Text] [Related]
8. Pharmacological reactivity of human epicardial coronary arteries: characterization of relaxation responses to endothelium-derived relaxing factor. Stork AP; Cocks TM Br J Pharmacol; 1994 Dec; 113(4):1099-104. PubMed ID: 7889260 [TBL] [Abstract][Full Text] [Related]
9. Prostacyclin and nitric oxide contribute to the vasodilator action of acetylcholine and bradykinin in the intact rabbit coronary bed. Lamontagne D; König A; Bassenge E; Busse R J Cardiovasc Pharmacol; 1992 Oct; 20(4):652-7. PubMed ID: 1280723 [TBL] [Abstract][Full Text] [Related]
10. Myocardial release of nitric oxide during ischaemia and reperfusion: effects of L-arginine and hypercholesterolaemia. Prasan AM; McCarron HC; Zhang Y; Jeremy RW Heart Lung Circ; 2007 Aug; 16(4):274-81. PubMed ID: 17420156 [TBL] [Abstract][Full Text] [Related]
11. Evidence for differential roles of nitric oxide (NO) and hyperpolarization in endothelium-dependent relaxation of pig isolated coronary artery. Kilpatrick EV; Cocks TM Br J Pharmacol; 1994 Jun; 112(2):557-65. PubMed ID: 7521260 [TBL] [Abstract][Full Text] [Related]
13. Role of endothelium-derived bradykinin in the control of vascular tone. Hecker M; Dambacher T; Busse R J Cardiovasc Pharmacol; 1992; 20 Suppl 9():S55-61. PubMed ID: 1282631 [TBL] [Abstract][Full Text] [Related]
14. Potentiation of the vasorelaxant activity of nitric oxide by hydroxyguanidine: implications for the nature of endothelium-derived relaxing factor. Zembowicz A; Swierkosz TA; Southan GJ; Hecker M; Vane JR Br J Pharmacol; 1992 Dec; 107(4):1001-7. PubMed ID: 1281716 [TBL] [Abstract][Full Text] [Related]
15. Thimerosal blocks stimulated but not basal release of endothelium-derived relaxing factor (EDRF) in dog isolated coronary artery. Crack P; Cocks T Br J Pharmacol; 1992 Oct; 107(2):566-72. PubMed ID: 1384915 [TBL] [Abstract][Full Text] [Related]
16. Display of the characteristics of endothelium-derived hyperpolarizing factor by a cytochrome P450-derived arachidonic acid metabolite in the coronary microcirculation. Bauersachs J; Hecker M; Busse R Br J Pharmacol; 1994 Dec; 113(4):1548-53. PubMed ID: 7889312 [TBL] [Abstract][Full Text] [Related]
17. Evidence that mechanisms dependent and independent of nitric oxide mediate endothelium-dependent relaxation to bradykinin in human small resistance-like coronary arteries. Kemp BK; Cocks TM Br J Pharmacol; 1997 Mar; 120(5):757-62. PubMed ID: 9138678 [TBL] [Abstract][Full Text] [Related]
18. On-line measurement of nitric oxide release from organic nitrates in the intact coronary circulation. Schrör K; Förster S; Woditsch I Naunyn Schmiedebergs Arch Pharmacol; 1991 Aug; 344(2):240-6. PubMed ID: 1719435 [TBL] [Abstract][Full Text] [Related]
19. Type 1 diabetes and hypercholesterolaemia reveal the contribution of endothelium-derived hyperpolarizing factor to endothelium-dependent relaxation of the rat aorta. Malakul W; Thirawarapan S; Suvitayavat W; Woodman OL Clin Exp Pharmacol Physiol; 2008 Feb; 35(2):192-200. PubMed ID: 17941894 [TBL] [Abstract][Full Text] [Related]
20. Supplementation of hypercholesterolaemic rabbits with L-arginine reduces the vascular release of superoxide anions and restores NO production. Böger RH; Bode-Böger SM; Mügge A; Kienke S; Brandes R; Dwenger A; Frölich JC Atherosclerosis; 1995 Oct; 117(2):273-84. PubMed ID: 8801873 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]